Sep 9, 2015 07:40AM Needham & Company Downgrades Tetraphase Pharmaceuticals (TTPH) to Hold

Aug 6, 2015 08:56AM Needham & Company Raises Price Target on Tetraphase Pharma (TTPH) to $56 Ahead of Phase 3 cUTI Results

Apr 7, 2015 07:00AM Tetraphase Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference

Dec 18, 2014 07:29AM Tetraphase Pharmaceuticals (TTPH) Target Raised to $46 at Needham & Company

Nov 24, 2014 09:31AM Pre-Open Stock Movers 11/24: (RNA) (CIMT) (PTP) Higher; (LGF) (TSL) (CBI) Lower (more...)

Oct 17, 2014 07:46AM Tetraphase Pharma (TTPH) Prices 3.95M Common Offering at $19/Share

Oct 15, 2014 06:03PM Tetraphase Pharma (TTPH) to Offer $75M in Stock

Oct 7, 2014 06:30AM Tetraphase Pharmaceuticals (TTPH) PT Lifted to $28 at Needham & Company as Core Eravacycline Phase 3 cUTI Trial Initiated

Sep 3, 2014 09:26AM Pre-Open Stock Movers 9/3: (ISNS) (INFI) (BTH) Higher; (END) (DGLY) (HELE) Lower (more...)

Mar 6, 2014 01:32PM Tetraphase Pharmaceuticals (TTPH) Target Lifted to $17 at Needham & Company

Nov 4, 2013 06:30AM Tetraphase Pharma (TTPH) Announces 3.3M Common Stock Offering

Oct 1, 2013 08:26AM Tetraphase (TTPH) PT Raised to $15 as Phase 3 Trial Ready

Apr 15, 2013 10:29AM Notable Analyst Rating Changes 04/15: (JCP) (CMG) (UA) Upgraded; (UNTK) (ABX) (PAAS) Downgraded

Apr 15, 2013 07:59AM Needham & Company Starts Tetraphase Pharmaceuticals (TTPH) at Buy

Mar 20, 2013 10:15AM Tetraphase Pharmaceuticals (TTPH) IPO Opens, Trades Flat

Mar 20, 2013 09:47AM Tetraphase (TTPH) Prices 10.7M IPO at $7/Share